They demonstrated that the T cell function in tumor-bearing mice enhances antitumor response compared with an oncolytic control by designing an oncolytic virus to express leptin, as well as promoting memory responses in the oncolytic virus-induced immune infiltrate. This evidence concerns the gene LEP and neoplasm.